![Rocket Pharmaceuticals, Inc. logo](/logos/RCKT.webp)
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
Overview | Financials
Company Name | Rocket Pharmaceuticals, Inc. |
Symbol | RCKT |
Currency | USD |
Price | 18.51 |
Market Cap | 1,683,963,909 |
Dividend Yield | 0% |
52-week-range | 15.27 - 32.525 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Gaurav D. Shah M.D. |
Website | https://rocketpharma.com |
An error occurred while fetching data.
About Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD